BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 20144347)

  • 21. [Nutrition management in obese patients with type 2 diabetes mellitus after laparoscopic sleeve gastrectomy].
    Tang W; Chen Y; Pan M; Chen L; Zhang L; Wang T; Zhang X; Zhang P; Zheng C; Yu B
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):411-416. PubMed ID: 28440522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of bariatric-metabolic surgery in the treatment of obese type 2 diabetes with body mass index <35 kg/m2: a literature review.
    Reis CE; Alvarez-Leite JI; Bressan J; Alfenas RC
    Diabetes Technol Ther; 2012 Apr; 14(4):365-72. PubMed ID: 22176155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term outcomes in gastric bypass patients with and without type 2 diabetes--Waitemata District Health Board experience.
    Lam AH; Kim DD; Cutfield R; Walker C; Booth M
    N Z Med J; 2013 Nov; 126(1386):21-30. PubMed ID: 24316990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of taspoglutide on glycemic control and body weight in obese patients with type 2 diabetes (T-emerge 7 study).
    Hollander P; Lasko B; Barnett AH; Bengus M; Kanitra L; Pi-Sunyer FX; Balena R
    Obesity (Silver Spring); 2013 Feb; 21(2):238-47. PubMed ID: 23404788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetes remission and insulin secretion after gastric bypass in patients with body mass index <35 kg/m2.
    Lee WJ; Chong K; Chen CY; Chen SC; Lee YC; Ser KH; Chuang LM
    Obes Surg; 2011 Jul; 21(7):889-95. PubMed ID: 21499957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Triglyceride/HDL Ratio and Triglyceride Glucose Index as Predictors of Glycemic Control in Patients with Diabetes Mellitus Type 2.
    Babic N; Valjevac A; Zaciragic A; Avdagic N; Zukic S; Hasic S
    Med Arch; 2019 Jun; 73(3):163-168. PubMed ID: 31404127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative effectiveness of bariatric surgery and nonsurgical therapy in adults with type 2 diabetes mellitus and body mass index <35 kg/m2.
    Serrot FJ; Dorman RB; Miller CJ; Slusarek B; Sampson B; Sick BT; Leslie DB; Buchwald H; Ikramuddin S
    Surgery; 2011 Oct; 150(4):684-91. PubMed ID: 22000180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial.
    Mingrone G; Panunzi S; De Gaetano A; Guidone C; Iaconelli A; Nanni G; Castagneto M; Bornstein S; Rubino F
    Lancet; 2015 Sep; 386(9997):964-73. PubMed ID: 26369473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preoperative fasting plasma C-peptide level may help to predict diabetes outcome after gastric bypass surgery.
    Aarts EO; Janssen J; Janssen IM; Berends FJ; Telting D; de Boer H
    Obes Surg; 2013 Jul; 23(7):867-73. PubMed ID: 23475775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of high protein vs high carbohydrate intake on insulin sensitivity, body weight, hemoglobin A1c, and blood pressure in patients with type 2 diabetes mellitus.
    Sargrad KR; Homko C; Mozzoli M; Boden G
    J Am Diet Assoc; 2005 Apr; 105(4):573-80. PubMed ID: 15800559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postprandial glucose monitoring further improved glycemia, lipids, and weight in persons with type 2 diabetes mellitus who had already reached hemoglobin A1c goal.
    Zhang DA; Katznelson L; Li M
    J Diabetes Sci Technol; 2012 Mar; 6(2):289-93. PubMed ID: 22538137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Five-year outcomes of patients with type 2 diabetes who underwent laparoscopic adjustable gastric banding.
    Sultan S; Gupta D; Parikh M; Youn H; Kurian M; Fielding G; Ren-Fielding C
    Surg Obes Relat Dis; 2010; 6(4):373-6. PubMed ID: 20627708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can Sleeve Gastrectomy "Cure" Diabetes? Long-term Metabolic Effects of Sleeve Gastrectomy in Patients With Type 2 Diabetes.
    Aminian A; Brethauer SA; Andalib A; Punchai S; Mackey J; Rodriguez J; Rogula T; Kroh M; Schauer PR
    Ann Surg; 2016 Oct; 264(4):674-81. PubMed ID: 27433906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Type 2 Diabetes Remission and Control in Overweight and in Mildly Obese Diabetic Patients at Long-Term Follow-Up After Biliopancreatic Diversion.
    Adami GF; Camerini G; Papadia F; Catalano MF; Carlini F; Cordera R; Scopinaro N
    Obes Surg; 2019 Jan; 29(1):239-245. PubMed ID: 30232725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetes in urban African Americans. III. Management of type II diabetes in a municipal hospital setting.
    Ziemer DC; Goldschmid MG; Musey VC; Domin WS; Thulé PM; Gallina DL; Phillips LS
    Am J Med; 1996 Jul; 101(1):25-33. PubMed ID: 8686711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial.
    Halperin F; Ding SA; Simonson DC; Panosian J; Goebel-Fabbri A; Wewalka M; Hamdy O; Abrahamson M; Clancy K; Foster K; Lautz D; Vernon A; Goldfine AB
    JAMA Surg; 2014 Jul; 149(7):716-26. PubMed ID: 24899464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes: A 1-year randomized controlled trial.
    Kelley DE; Bray GA; Pi-Sunyer FX; Klein S; Hill J; Miles J; Hollander P
    Diabetes Care; 2002 Jun; 25(6):1033-41. PubMed ID: 12032111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of naltrexone sustained-release/bupropion sustained-release combination therapy on body weight and glycemic parameters in overweight and obese patients with type 2 diabetes.
    Hollander P; Gupta AK; Plodkowski R; Greenway F; Bays H; Burns C; Klassen P; Fujioka K;
    Diabetes Care; 2013 Dec; 36(12):4022-9. PubMed ID: 24144653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in glycemic control and body weight after explantation of the duodenal-jejunal bypass liner.
    Betzel B; Koehestanie P; Homan J; Aarts EO; Janssen IM; de Boer H; Wahab PJ; Groenen MJ; Berends FJ
    Gastrointest Endosc; 2017 Feb; 85(2):409-415. PubMed ID: 27451295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intermittent Vagal Nerve Block for Improvements in Obesity, Cardiovascular Risk Factors, and Glycemic Control in Patients with Type 2 Diabetes Mellitus: 2-Year Results of the VBLOC DM2 Study.
    Shikora SA; Toouli J; Herrera MF; Kulseng B; Brancatisano R; Kow L; Pantoja JP; Johnsen G; Brancatisano A; Tweden KS; Knudson MB; Billington CJ
    Obes Surg; 2016 May; 26(5):1021-8. PubMed ID: 26471783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.